Your browser doesn't support javascript.
loading
IFCC Working Group Recommendations for Assessing Commutability Part 1: General Experimental Design.
Miller, W Greg; Schimmel, Heinz; Rej, Robert; Greenberg, Neil; Ceriotti, Ferruccio; Burns, Chris; Budd, Jeffrey R; Weykamp, Cas; Delatour, Vincent; Nilsson, Göran; MacKenzie, Finlay; Panteghini, Mauro; Keller, Thomas; Camara, Johanna E; Zegers, Ingrid; Vesper, Hubert W.
Afiliación
  • Miller WG; Department of Pathology, Virginia Commonwealth University, Richmond, VA; gmiller@vcu.edu.
  • Schimmel H; European Commission, Joint Research Centre (JRC), Directorate F, Geel, Belgium.
  • Rej R; Wadsworth Center for Laboratories and Research, New York State Department of Health, and School of Public Health, State University of New York at Albany, Albany, NY.
  • Greenberg N; Neil Greenberg Consulting, LLC, Rochester, NY.
  • Ceriotti F; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Burns C; National Institute for Biological Standards and Control, A Centre of the MHRA, Hertfordshire, UK.
  • Budd JR; Beckman Coulter, Chaska, MN.
  • Weykamp C; Queen Beatrix Hospital, Winterswijk, the Netherlands.
  • Delatour V; Laboratoire national de métrologie et d'essais (LNE), Paris, France.
  • Nilsson G; Uppsala, Sweden.
  • MacKenzie F; Birmingham Quality/UK NEQAS, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Panteghini M; Research Centre for Metrological Traceability in Laboratory Medicine (CIRME), University of Milan, Milan, Italy.
  • Keller T; ACOMED Statistic, Leipzig, Germany.
  • Camara JE; National Institute of Standards and Technology, Gaithersburg, MD.
  • Zegers I; European Commission, Joint Research Centre (JRC), Directorate F, Geel, Belgium.
  • Vesper HW; Centers for Disease Control and Prevention, Atlanta, GA.
Clin Chem ; 64(3): 447-454, 2018 03.
Article en En | MEDLINE | ID: mdl-29348163
ABSTRACT
Commutability is a property of a reference material (RM) that relates to the closeness of agreement between results for an RM and results for clinical samples (CSs) when measured by ≥2 measurement procedures (MPs). Commutability of RMs used in a calibration traceability scheme is an essential property for them to be fit for purpose. Similarly, commutability of trueness controls or external quality assessment samples is essential when those materials are used to assess trueness of results for CSs. This report is part 1 of a 3-part series describing how to assess commutability of RMs. Part 1 defines commutability and addresses critical components of the experimental design for commutability assessment, including selection of individual CSs, use of pooled CSs, qualification of MPs for inclusion, establishing criteria for the determination that an RM is commutable, generalization of commutability conclusions to future measurements made with the MPs included in the assessment, and information regarding commutability to be included in the certificate for an RM. Parts 2 and 3 in the series present 2 different statistical approaches to commutability assessment that use fixed criteria related to the medical decisions that will be made using the laboratory test results.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Técnicas de Laboratorio Clínico Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Clin Chem Asunto de la revista: QUIMICA CLINICA Año: 2018 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Técnicas de Laboratorio Clínico Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Clin Chem Asunto de la revista: QUIMICA CLINICA Año: 2018 Tipo del documento: Article